Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens-Reference-Cited by-同舟云学术

Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens

Published:2023-03 Issue:3 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Wang Ting¹,Zheng Lilan²³,Zhao Qiujian¹,Yao Yazhou¹,Zhou Feng¹,Wei Fang⁴,Cai Qiliang²⁵^ORCID

Affiliation:

1. Department of Clinical Laboratory Baoji Central Hospital Baoji China

2. MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Shanghai Medical College Fudan University Shanghai China

3. Department of Clinical Laboratory Fujian Provincial Hospital South Branch Fuzhou Fujian China

4. ShengYushou Center of Cell Biology and Immunology, Joint International Research Laboratory of Metabolic and Development Sciences, School of Life Sciences and Biotechnology Shanghai Jiao Tong University Shanghai China

5. Expert Workstation Baoji Central Hospital Baoji China

Abstract

AbstractParainfluenza virus 5 (PIV5) is a negative‐sense, single‐stranded RNA virus that can infect humans and many species of animals. Infection in these reservoir hosts is generally asymptomatic and has few safety concerns. Emerging evidence has shown that PIV5 is a promising vector for developing vaccines against human infectious diseases caused by coronaviruses, influenza, respiratory syncytial virus, rabies, HIV, or bacteria. In this review, we summarize recent progress and highlight the advantages and strategies of PIV5 as a vaccine vector to improve future vaccine design and application for clinical trials.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28622

Reference126 articles.

1. New Vaccine Technologies to Combat Outbreak Situations

2. Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19

3. The use of viral vectors in vaccine development

4. Viruses as vaccine vectors for infectious diseases and cancer

5. New viral vectors for infectious diseases and cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing of a multi-epitopes based vaccine against Haemophilius parainfluenzae and its validation through integrated computational approaches;Frontiers in Immunology;2024-04-16

2. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses;Journal of Virology;2024-03-19

3. Diversity of species and geographic distribution of tick-borne viruses in China;Frontiers in Microbiology;2024-02-27

4. Molecular biology of canine parainfluenza virus V protein and its potential applications in tumor immunotherapy;Frontiers in Microbiology;2023-12-20